California Nanotechnologies Corp.
CNO.V
TSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -17.79% | 13.45% | 86.51% | 123.06% | 173.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.79% | 13.45% | 86.51% | 123.06% | 173.95% |
| Cost of Revenue | -8.01% | -2.01% | 63.09% | 86.83% | 163.55% |
| Gross Profit | -21.54% | 20.09% | 96.59% | 138.80% | 178.15% |
| SG&A Expenses | 40.44% | 56.23% | 69.04% | 108.54% | 148.66% |
| Depreciation & Amortization | 124.87% | 183.19% | 297.53% | 191.03% | 112.71% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.55% | 41.17% | 79.21% | 105.84% | 150.78% |
| Operating Income | -137.85% | -68.17% | 117.54% | 178.73% | 260.18% |
| Income Before Tax | -546.53% | -208.82% | -97.25% | -129.97% | -44.26% |
| Income Tax Expenses | 21,112.50% | 21,212.50% | -- | -102.44% | -116.67% |
| Earnings from Continuing Operations | -641.61% | -224.96% | -141.50% | -130.13% | -43.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -641.61% | -224.96% | -141.50% | -130.13% | -43.15% |
| EBIT | -137.85% | -68.17% | 117.54% | 178.73% | 260.18% |
| EBITDA | -104.39% | -51.01% | 111.75% | 153.05% | 212.29% |
| EPS Basic | -368.00% | -198.96% | -123.08% | -124.24% | -21.05% |
| Normalized Basic EPS | -334.09% | -187.78% | -100.00% | -125.52% | -27.87% |
| EPS Diluted | -436.84% | -268.02% | -212.05% | -167.84% | -141.76% |
| Normalized Diluted EPS | -313.64% | -184.85% | -95.06% | -124.09% | -24.14% |
| Average Basic Shares Outstanding | 12.56% | 20.34% | 29.35% | 36.63% | 28.49% |
| Average Diluted Shares Outstanding | 14.08% | 27.00% | 36.17% | 43.64% | 34.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |